Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-292,467
Closed -$2.13M 431
2025
Q1
$2.13M Sell
292,467
-487,806
-63% -$4.27M 0.05% 145
2024
Q4
$6.1M Sell
780,273
-30,260
-4% -$249K 0.11% 133
2024
Q3
$6M Sell
810,533
-1,370,398
-63% -$11.5M 0.08% 104
2024
Q2
$17.5M Sell
2,180,931
-518,539
-19% -$4.63M 0.21% 81
2024
Q1
$31.4M Sell
2,699,470
-4,732
-0.2% -$52.4K 0.27% 81
2023
Q4
$30.2M Buy
2,704,202
+1,498,564
+124% +$13.8M 0.26% 83
2023
Q3
$18.6M Buy
1,205,638
+478,632
+66% +$8.03M 0.11% 152
2023
Q2
$13.8M Buy
727,006
+290,121
+66% +$5.09M 0.08% 189
2023
Q1
$6.65M Buy
436,885
+249,785
+134% +$3.26M 0.05% 224
2022
Q4
$2.38M Hold
187,100
0.01% 305
2022
Q3
$1.08M Hold
187,100
0.01% 365
2022
Q2
$602K Buy
+187,100
New +$565K 0.01% 321

Other funds holding ETNB

Laurion Capital Management's ETNB Position: Q2 2025 in Review

Laurion Capital Management sold out of 89bio (ETNB) in Q2 2025, closing a stake of 292,467 shares — an estimated $2.13M sold.

Laurion Capital Management first reported a position in ETNB in Q2 2022 and held it in 12 quarters. The position peaked at $31.4M in Q1 2024. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • Laurion Capital Management reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
  • Laurion Capital Management sold 292,467 89bio shares in Q2 2025, an estimated $2.13M.
  • Laurion Capital Management first reported a position in 89bio in Q2 2022 and held it in 12 quarters.
  • Laurion Capital Management's 89bio position peaked at $31.4M in Q1 2024.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on Laurion Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.